Literature DB >> 12909325

Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction.

Hiroyuki Yoshida1, Masaya Takahashi, Miki Koshimizu, Kouichi Tanonaka, Ryo Oikawa, Teruhiko Toyo-oka, Satoshi Takeo.   

Abstract

OBJECTIVE: Genetic defects in several sarcoglycans (SGs) and dystrophin (Dys) play a critical role in cardiomyopathy. The present study was designed to determine whether changes in SGs and Dys might occur in animals with chronic heart failure (CHF) induced by acute myocardial infarction (AMI), which have no genetic defects.
METHODS: AMI was induced by the left coronary artery ligation (CAL) in rats. The hemodynamic parameters of the 2- and 8-week CAL (2w- and 8w-CAL) rats were measured and the myocardial SGs, Dys, calpain, and calpastatin levels were determined by the Western blot method. Myocardial calpain-like protease activity was evaluated as caseinolysis activity.
RESULTS: Increases in left ventricular end-diastolic pressure (LVEDP) and right ventricular systolic pressure, and a decrease in +/-dP/dt were observed at the 2nd week, whereas cardiac output index (COI) was preserved. In contrast, the 8w-CAL rats showed a further increment in LVEDP with low COI. alpha-SG of the viable left ventricle (LV), and septum (Sep) of the 8w-CAL rat decreased (60-70% of the control). The alpha- and beta-SGs of the right ventricle (RV) of the 2w- and 8w-CAL rats were reduced, while gamma- and delta-SGs in the three regions did not change significantly. Dys in the viable LV and RV of the 8w-CAL rat decreased (75% of the control). The amount of m-calpain in the three regions of the 2w- and 8w-CAL rats increased (140-200% of the control), whereas the endogenous calpain inhibitor, calpastatin, did not change significantly. The in vitro degradation studies using purified m-calpain or cytosolic fractions of the 8w-CAL rat heart suggested a reduction in SGs and Dys by calpain.
CONCLUSION: The results suggest that a decrease in SGs and Dys may play an important role in the pathophysiology of CHF following AMI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909325     DOI: 10.1016/s0008-6363(03)00385-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

1.  Intracellular energetic units in healthy and diseased hearts.

Authors:  Enn K Seppet; Margus Eimre; Tiia Anmann; Evelin Seppet; Nadezhda Peet; Tuuli Käämbre; Kalju Paju; Andres Piirsoo; Andrei V Kuznetsov; Marko Vendelin; Frank N Gellerich; Stephan Zierz; Valdur A Saks
Journal:  Exp Clin Cardiol       Date:  2005

2.  Isoproterenol induces primary loss of dystrophin in rat hearts: correlation with myocardial injury.

Authors:  Erica C Campos; Minna M D Romano; Cibele M Prado; Marcos A Rossi
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

3.  Dantrolene improves in vitro structural changes induced by serum from Trypanosoma cruzi-infected mice.

Authors:  Lygia M Malvestio; Mara Rúbia N Celes; Linda A Jelicks; Herbert B Tanowitz; Cibele M Prado
Journal:  Parasitol Res       Date:  2016-10-11       Impact factor: 2.289

Review 4.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 5.  Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy.

Authors:  David Aluja; Sara Delgado-Tomás; Marisol Ruiz-Meana; José A Barrabés; Javier Inserte
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

6.  Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization.

Authors:  Joshua J Martindale; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2013-12-19       Impact factor: 5.000

7.  Specific knockdown of delta-sarcoglycan gene in C2C12 in vitro causes post-translational loss of other sarcoglycans without mechanical stress.

Authors:  Michiyo Honda; Mari Hosoda; Nobuyuki Kanzawa; Takahide Tsuchiya; Teruhiko Toyo-oka
Journal:  Mol Cell Biochem       Date:  2008-12-16       Impact factor: 3.396

8.  Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling.

Authors:  Yoko Kudo-Sakamoto; Hiroshi Akazawa; Kaoru Ito; Jiro Takano; Masamichi Yano; Chizuru Yabumoto; Atsuhiko T Naito; Toru Oka; Jong-Kook Lee; Yasushi Sakata; Jun-ichi Suzuki; Takaomi C Saido; Issei Komuro
Journal:  J Biol Chem       Date:  2014-06-02       Impact factor: 5.157

9.  Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction.

Authors:  Teruhiko Toyo-Oka; Tomie Kawada; Jumi Nakata; Han Xie; Masashi Urabe; Fujiko Masui; Takashi Ebisawa; Asaki Tezuka; Kuniaki Iwasawa; Toshiaki Nakajima; Yoshio Uehara; Hiroyuki Kumagai; Sawa Kostin; Jutta Schaper; Mikio Nakazawa; Keiya Ozawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

10.  Over-expression of calpastatin inhibits calpain activation and attenuates post-infarction myocardial remodeling.

Authors:  Tingqiao Ye; Qiang Wang; Yan Zhang; Xiaofeng Song; Dachun Yang; De Li; Dan Li; Linan Su; Yongjian Yang; Shuangtao Ma
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.